[1]朱娉,姜志昕,郝朋,等.ROCK抑制剂Y-27632在体外培养的兔角膜内皮细胞紫外线损伤修复中的作用[J].眼科新进展,2021,41(3):201-205.[doi:10.13389/j.cnki.rao.2021.0042]
 ZHU Ping,JIANG Zhixin,HAO Peng,et al.Roles of ROCK inhibitor Y-27632 on rabbit corneal endothelial cells against ultraviolet radiation-induced damage in vitro[J].Recent Advances in Ophthalmology,2021,41(3):201-205.[doi:10.13389/j.cnki.rao.2021.0042]
点击复制

ROCK抑制剂Y-27632在体外培养的兔角膜内皮细胞紫外线损伤修复中的作用/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年3期
页码:
201-205
栏目:
实验研究
出版日期:
2021-03-05

文章信息/Info

Title:
Roles of ROCK inhibitor Y-27632 on rabbit corneal endothelial cells against ultraviolet radiation-induced damage in vitro
作者:
朱娉姜志昕郝朋赵堪兴李轩
300020 天津市,天津市眼科医院 天津市眼科学与视觉科学重点实验室 天津市眼科研究所 天津医科大学眼科临床学院 南开大学附属眼科医院
Author(s):
ZHU PingJIANG ZhixinHAO PengZHAO KanxingLI Xuan
Tianjin Eye Hospital,Tianjin Key Laboratory of Ophthalmology and Vision Science,Tianjin Eye Institute,Clinical College of Ophthalmology,Tianjin Medical University,Affiliated Eye Hospital of Nankai University,Tianjin 300020,China
关键词:
角膜内皮细胞 ROCK抑制剂增殖黏附性细胞周期蛋白细胞周期蛋白依赖激酶 细胞周期蛋白依赖激酶抑制因子
Keywords:
corneal endothelium ROCK inhibitor proliferation adhesion CyclinD1 Cdk2 CDKN1B
分类号:
R771
DOI:
10.13389/j.cnki.rao.2021.0042
文献标志码:
A
摘要:
目的 探讨ROCK抑制剂Y-27632在兔角膜内皮细胞(rabbit corneal endothelial cells,RCECs)紫外线损伤修复中的作用。方法 收集30只健康成年新西兰大白兔的角膜,显微镜下撕除角膜后弹力层和内皮层,用胰蛋白酶消化法获得原代RCECs。选取第2代处于对数生长期的RCECs分为三组:A组为正常对照组,RCECs为常规培养液培养;B组为紫外线照射组,RCECs经紫外线照射20 s制备细胞损伤模型,常规内皮细胞培养液培养;C组为紫外线照射+Y-27632组,在细胞损伤模型中加入终浓度10 μmol·L-1的Y-27632细胞培养液培养。采用MTT比色法检测各组细胞活性。采用Transwell迁移实验检测各组细胞的迁移能力。利用BrdU细胞增殖实验检测各组细胞的增殖能力。运用细胞黏附实验检测各组细胞黏附性。采用实时荧光定量PCR法检测各组细胞周期蛋白(CyclinD1)和细胞周期蛋白依赖激酶抑制因子(CDKN1B)mRNA的相对表达量。Western blot法检测各组CyclinD1和细胞周期蛋白依赖激酶(Cdk2)的表达情况。结果 MTT比色法检测结果显示,B组细胞的活性(80.61±3.40)%低于A组(100%)和C组(92.55±4.56)%,差异均有统计学意义(P=0.000、0.025)。Transwell迁移实验结果显示,B组迁移细胞数目[(39.3±4.4)个/高倍视野]较A组[(77.0±6.7)个/高倍视野]和C组[(54.3±3.4)个/高倍视野]减少,差异均有统计学意义(P=0.023、0.015)。BrdU细胞增殖实验检测结果显示,B组细胞光密度值(0.24±0.05)较A组(0.35±0.08)和C组(0.30±0.07)降低,差异均有统计学意义(P=0.001、0.015)。细胞黏附实验结果显示,B组细胞黏附性(0.183±0.010)较A组(0.541±0.010)和C组(0.353±0.030)下降,差异均有统计学意义(P=0.001、0.000)。实时荧光定量PCR检测结果显示,与A组相比,B组的CyclinD1 mRNA相对表达量(0.49±0.10)下降,CDKN1B mRNA相对表达量(1.25±0.20)上调,差异均有统计学意义(P=0.003、0.002);C组CyclinD1 mRNA的相对表达量(0.80±0.12)比B组(0.49±0.10)增加,C组CDKN1B mRNA的相对表达量(0.90±0.16)比B组(1.25±0.20)减少,差异均有统计学意义(P=0.013、0.022)。Western blot检测结果显示,B组CyclinD1、Cdk2蛋白表达量分别为(0.21±0.09)和(0.38±0.10),均低于A组(0.43±0.12)、(0.62±0.19),差异均有统计学意义(P=0.014、0.005);C组CyclinD1、Cdk2蛋白表达量分别为(0.34±0.11)和(0.51±0.14),均高于B组,差异均有统计学意义(P=0.027、0.002)。结论 ROCK抑制剂Y-27632能增强紫外线损伤的RCECs活性,促进细胞迁移、黏附和增殖。
Abstract:
Objective To investigate the roles of ROCK inhibitor Y-27632 on rabbit corneal endothelial cells (RCECs) from ultraviolet (UV) radiation-induced damage in vitro.Methods The corneas of 30 healthy adult New Zealand white rabbits were collected, the Descemet’s membrane was tore off under a microscope, and primary RCECs were obtained by trypsin digestion. The second generation of RCECs in the logarithmic growth phase were collected and divided into three groups:group A was the normal control group, and RCECs were cultured in conventional medium, group B was UV radiation-induced RCECs damage group, and RCECs were irradiated with ultraviolet for 20 s, then cultured in conventional endothelial cell culture medium, group C was the ultraviolet irradiation + Y-27632 group, RCECs were irradiated with ultraviolet for 20 s, then cultured in culture medium with Y-27632 at the final concentration of 10 μmol·L-1. The cell viability of RCECs was examined by MTT assay. Cell migration was measured by Transwell chamber experiment. The proliferation of RCECs was evaluated by BrdU cell proliferation assay. The cell adhesion of RCECs was assessed by cell adhesion assay. The Real-time fluorescence quantitative PCR was used to detect the relative expression levels of CyclinD1 mRNA and CDKN1B mRNA in cells. Western blot was used to detect the protein expression of CyclinD1 and Cdk2 in cells.Results The results of MTT test showed that the cell viability of group B [(80.61±3.40)%] was lower than that of group A (100%) and group C [(92.55±4.56)%], and the differences were statistically significant (P=0.000,0.025). The results of the Transwell migration experiment showed that the number of migrating cells in group B [(39.3±4.4)cells/high magnification] was lower than that of group A [(77.0±6.7)cells/ high magnification] and group C [(54.3±3.4)cells/ high magnification] , and the differences were statistically significant (P=0.023, 0.015). The results of BrdU cell proliferation experiment showed that the cell proliferation ability of group B (0.24±0.05) was lower than that of group A (0.35±0.08) and group C (0.30±0.07), and the differences were statistically significant (P=0.001, 0.015) . The results of cell adhesion experiment showed that the cell adhesion of group B (0.183±0.010) was lower than that of group A (0.541±0.010) and group C (0.353±0.030), and the differences were statistically significant (P=0.001, 0.000). Real-time fluorescence quantitative PCR showed that compared with group A (1.00±0.00), the relative expression level of CyclinD1 mRNA in group B (0.49±0.10) decreased, and the relative expression level of CDKN1B mRNA in group B (1.25±0.20) increased, and the differences were statistically significant (P=0.003, 0.002); the relative expression of CyclinD1 mRNA in group C (0.80±0.12) was higher than that in group B (0.49±0.10), and the relative expression of CDKN1B mRNA in group C (0.90±0.16) was lower than that in group B (1.25 ±0.20), and the differences were statistically significant (P=0.013, 0.022). Western blot showed that the protein expression levels of CyclinD1 and Cdk2 in group B were (0.21±0.09) and (0.38±0.10), respectively, which were lower than those in group A (0.43±0.12) and (0.62±0.19), and the differences were statistically significant (P=0.014, 0.005); the protein expression levels of CyclinD1 and Cdk2 in group C were (0.34±0.11) and (0.51±0.14), which were higher than those in group B, and the differences were statistically significant (P=0.027, 0.002). Conclusion ROCK inhibitor Y-27632 can enhance the viability of RCECs from UV radiation-induced damage, and promote cell migration, adhesion and proliferation.

参考文献/References:

[1] MURPHY C,ALVARADO J,JUSTER R,MAGLIO M.Prenatal and postnatal cellularity of the human corneal endothelium.A quantitative histologic study[J].Invest Ophthalmol Vis Sci,1984,25(3):312-322.
[2] GAIN P,JULLIENNE R,HE Z,ALDOSSARY M,ACQUART S,COGNASSE F,et al.Global survey of corneal transplantation and eye banking[J].JAMA Ophthalmol,2016,134(2):167-173.
[3] NARUMIYA S,TANJI M,ISHIZAKI T.Rho signaling,rock and mdia1,in transformation,metastasis and invasion[J].Cancer Metastasis Rev,2009,28(1-2):65-76.
[4] OKUMURA N,OKAZAKI Y,INOUE R,KAKUTANI K,NAKANO S,KINOSHITA S,et al.Effect of the rho-associated kinase inhibitor eye drop (ripasudil) on corneal endothelial wound healing[J].Invest Ophthalmol Vis Sci,2016,57(3):1284-1292.
[5] KINOSHITA S,KOIZUMI N,UENO M,OKUMURA N,IMAI K,TANAKA H,et al.Injection of cultured cells with a rock inhibitor for bullous keratopathy[J].N Engl J Med,2018,378(11):995-1003.
[6] JOYCE N C,ZHU C C,HARRIS D L.Relationship among oxidative stress,DNA damage,and proliferative capacity in human corneal endothelium[J].Invest Ophthalmol Vis Sci,2009,50(5):2116-2122.
[7] OKUMURA N,KINOSHITA S,KOIZUMI N.Application of rho kinase inhibitors for the treatment of corneal endothelial diseases[J].J Ophthalmol,2017,2017:2646904.
[8] HAN S B,LIU Y C,MOHAMED-NORIEGA K,MEHTA J S.Application of novel drugs for corneal cell regeneration[J].J Ophthalmol,2018,2018:1215868.
[9] ACHIRON A,FELDMAN A,KARMONA L,PE’ER L,AVIZEMER H,BARTOV E,et al.Effect of rho-associated kinase inhibitor on human corneal endothelial cell apoptosis[J].J Cataract Refract Surg,2020,46(4):612-616.
[10] MIYAGI H,KIM S,LI J,MURPHY C J,THOMASY S M.Topical rho-associated kinase inhibitor,y27632,accelerates corneal endothelial regeneration in a canine cryoinjury model[J].Cornea,2019,38(3):352-359.
[11] ZHANG W,YU F,CHEN J,FU Y,SHAO C,FAN X.Y-27632 promotes the healing of corneal endothelial wounds using endothelial progenitor cells derived from umbilical cord blood[J].Cornea,2020,40(2):203-214.
[12] WU Q,OUYANG C,XIE L,LING Y,HUANG T.The rock inhibitor,thiazovivin,inhibits human corneal endothelialtomesenchymal transition/epithelialtomesenchymal transition and increases ionic transporter expression[J].Int J Mol Med,2017,40(4):1009-1018.
[13] JOYCE N C.Proliferative capacity of the corneal endothelium[J].Prog Retin Eye Res,2003,22(3):359-389.
[14] OKUMURA N,NAKANO S,KAY E P,NUMATA R,OTA A,SOWA Y,et al.Involvement of cyclin d and p27 in cell proliferation mediated by rock inhibitors y-27632 and y-39983 during corneal endothelium wound healing[J].Invest Ophthalmol Vis Sci,2014,55(1):318-329.

相似文献/References:

[1]朱勤 肖中男 孙晓梅 胡敏 刘海 胡竹林.超声乳化致恒河猴角膜内皮损伤动物模型的建立[J].眼科新进展,2013,33(2):000.
[2]王娜 刘振山 冯云 陈银银 薛志刚 范国平.角膜内皮细胞体外培养的研究进展[J].眼科新进展,2013,33(6):000.
[3]王建萍 马勇 朱涛 郭中兰 薛雨顺 李静 孙烨 王柯.前葡萄膜炎患者角膜内皮细胞的计算机图像分析[J].眼科新进展,2012,32(4):000.
[4]刘海凤 朱晓谦 余涵.青光眼术后低角膜内皮细胞密度白内障手术26例临床分析[J].眼科新进展,2012,32(8):000.
[5]吕莎 宋胜仿 李华 徐霁 苏杨 吴杨杨.糖尿病性白内障术后角膜内皮细胞的变化[J].眼科新进展,2012,32(8):000.
[6]赵恳.白内障超声乳化人工晶状体植入术对糖尿病患者角膜内皮细胞形态与功能的影响[J].眼科新进展,2013,33(4):000.
[7]江志坚 薛敏 董健鸿 朱茂丽 王敏华.年龄相关性白内障患者角膜内皮细胞特征分析[J].眼科新进展,2013,33(10):000.
[8]左慧懿,梁皓,罗霄,等. 前房维持器和黏弹剂在白内障超声乳化吸出术中应用对角膜内皮细胞的早期影响[J].眼科新进展,2014,34(4):355.[doi:10.13389/j.cnki.rao.2014.0096]
[9]张文佳,胡竹林,朱勤,等.人脐静脉血管内皮细胞在体移植替代猴角膜内皮细胞的形态学分析[J].眼科新进展,2014,34(11):1020.[doi:10.13389/j.cnki.rao.2014.0283]
 ZHANG Wen-Jia,HU Zhu-Lin,ZHU Qin,et al.Microstructure observation of human vascular endothelial cells transplantation in autograft to replace monkey corneal endothelial cells[J].Recent Advances in Ophthalmology,2014,34(3):1020.[doi:10.13389/j.cnki.rao.2014.0283]
[10]王静,莫纯坚. 1.8mm同轴微切口超声乳化白内障吸出术对角膜内皮细胞的损伤及修复研究[J].眼科新进展,2015,35(4):377.[doi:10.13389/j.cnki.rao.2015.0102]
 WANG Jing,MO Chun-Jian. Effects of l.8 mm coaxial micro-incision cataract phacoemulsification on damage and repair of corneal endothelial cells[J].Recent Advances in Ophthalmology,2015,35(3):377.[doi:10.13389/j.cnki.rao.2015.0102]

备注/Memo

备注/Memo:
国家自然科学基金项目(编号:81170828);天津市应用基础与前沿技术研究计划项目(编号:15JCZDJC35300);天津市卫生行业重点攻关项目(编号:14KGl33)
更新日期/Last Update: 2021-03-05